Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves (Q41187841)

28 September 2017

1 reference

title

Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves (English)

1 reference

28 September 2017

0 references

Levine HJ

1

1 reference

PubMed ID

8890799

28 September 2017

Gaasch WH

series ordinal

2

1 reference

PubMed ID

8890799

28 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Journal of the American College of Cardiology

28 September 2017

1 reference

28 September 2017

28

1 reference

28 September 2017

5

1 reference

28 September 2017

1083-1091

1 reference

Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of heart rate on aortic insufficiency as measured by a dye-dilution technique

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Direct determinations of aortic blood flow in patients with aortic regurgitation. Effects of alterations in heart rate, increased ventricular preload or afterload, and isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Quantitative Hemodynamic Effects of Heart Rate in Aortic Regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of increasing heart rate in patients with aortic regurgitation. Effect of incremental atrial pacing on scintigraphic, hemodynamic and thermodilution measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Hemodynamic resistance as a measure of functional impairment in aortic valvular stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

The effects of left ventricular load and contractility on mitral regurgitant orifice size and flow in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

THE INFLUENCE OF ARTERIAL PRESSURE ON MITRAL INCOMPETENCE IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of Afterload on Force-Velocity Relations and Contractile Element Work in the Intact Dog Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Optimum heart rate of large failing hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of the vasodilator therapy in regurgitant valvular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Captopril mediated decrease of aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Afterload reduction with nifedipine in aortic insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Reduced Systemic Vascular Resistance as Therapy for Severe Mitral Regurgitation of Valvular Origin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Beneficial effects of hydralazine in severe mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Comparison of single dose nifedipine and captopril for chronic severe mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Response of the left ventricle to nitroglycerin in patients with and without mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Treatment with hydralazine in mild to moderate mitral or aortic incompetence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

Nifedipine in Asymptomatic Patients with Severe Aortic Regurgitation and Normal Left Ventricular Function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900288-4

7 January 2021

10.1016/S0735-1097(96)00288-4

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8890799